116 related articles for article (PubMed ID: 16551137)
1. Unsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies.
Nykter M; Hunt KK; Pollock RE; El-Naggar AK; Taylor E; Shmulevich I; Yli-Harja O; Zhang W
Technol Cancer Res Treat; 2006 Apr; 5(2):177-82. PubMed ID: 16551137
[TBL] [Abstract][Full Text] [Related]
2. Molecular approaches to resolve diagnostic dilemmas: the case of gastrointestinal stromal tumor and leiomyosarcoma.
Trent JC; Lazar AJ; Zhang W
Future Oncol; 2007 Dec; 3(6):629-37. PubMed ID: 18041915
[TBL] [Abstract][Full Text] [Related]
3. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
4. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
[TBL] [Abstract][Full Text] [Related]
5. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies.
Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
7. Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors.
Ogino J; Asanuma H; Sakurai S; Matsuno Y; Miyokawa N; Yamashiro K; Fukazawa Y; Muraoka S; Iwaki Y; Kondo N; Hasegawa T
Pathol Int; 2010 Nov; 60(11):707-13. PubMed ID: 20946519
[TBL] [Abstract][Full Text] [Related]
8. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
[TBL] [Abstract][Full Text] [Related]
9. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall.
Lam MM; Corless CL; Goldblum JR; Heinrich MC; Downs-Kelly E; Rubin BP
Int J Gynecol Pathol; 2006 Jul; 25(3):288-92. PubMed ID: 16810068
[TBL] [Abstract][Full Text] [Related]
10. Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT.
Foster R; Solano S; Mahoney J; Fuller A; Oliva E; Seiden MV
Gynecol Oncol; 2006 May; 101(2):363-6. PubMed ID: 16439005
[TBL] [Abstract][Full Text] [Related]
11. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
[TBL] [Abstract][Full Text] [Related]
12. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
13. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
15. Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.
Buleje J; Acosta Ó; Guevara-Fujita M; Enriquez Y; Taxa L; Machicado E; Lizaraso-Caparó F; Fujita R
Rev Esp Enferm Dig; 2015 Feb; 107(2):72-8. PubMed ID: 25659388
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and Gastrointestinal Stromal Tumor.
Akçakaya P; Lui WO
Adv Exp Med Biol; 2015; 889():51-70. PubMed ID: 26658996
[TBL] [Abstract][Full Text] [Related]
17. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
18. [Histopathologic diagnosis of gastrointestinal stromal tumor (GIST)].
Orosz Z
Orv Hetil; 2005 May; 146(18 Suppl 1):923-8. PubMed ID: 15921306
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of gastrointestinal stromal tumors from minute specimens: cytomorphology, immunohistochemistry, and molecular diagnostic findings.
Layfield LJ; Wallander ML
Diagn Cytopathol; 2012 Jun; 40(6):484-90. PubMed ID: 22351482
[TBL] [Abstract][Full Text] [Related]
20. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
